The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

STOCKS NEWS EUROPE-UK small caps up 0.1 pct, lag blue chips

Wed, 10th Apr 2013 12:30

UK small caps are up 0.1 percent in afternoon trade, underperformingrises of 0.8 percent on both the mid-caps and the blue chips.

Shares in Akers Biosciences jump 22 percent to 1.45 pence after themaker of rapid diagnostic screening and testing products says it expectsfull-year sales to be "significantly ahead of current forecasts".

The trading update prompts Daniel Stewart to raise its sales forecasts forthe year to $4.5 million from $3.5 million and increase its price target on the'buy'-rated stock to 3.0 pence from 2.2 pence.

Shares in Genel rise 6.5 percent, boosted by news of a significantdiscovery at the Chia Surkh 10 well.

"The light oil discovery and impressive flow test results are encouraging,"analysts at Liberum Capital write.

"However, legitimate concern remains over the outlook in Kurdistan and weremain cautious pending a tangible framework defining availability of exportmarkets and payments. Ahead of further appraisal our forecasts are unchanged."

Reuters messaging rm://antonina.vorobyova.thomsonreuters.com@reuters.net

Related Shares

More News
8 Oct 2018 13:10

Akers Biosciences appoints chief executive after settling legal battle

(Sharecast News) - Akers Biosciences appointed Howard Yeaton as chief executive on Monday as the company reached a settlement in its legal dispute wit...

15 Aug 2018 08:04

Akers Biosciences profits hit over antigen difficulties

(Sharecast News) - Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid as...

3 Apr 2018 13:45

Akers Biosciences 2017 Revenue Rises But Loss Widens On Higher Costs

LONDON (Alliance News) - Akers Biosciences Inc on Tuesday said revenue grew in 2017, but its loss widened due to increased costs across the business.T...

16 Mar 2018 18:11

Akers Biosciences Nets USD49,000 From Warrants Exercise (ALLISS)

LONDON (Alliance News) - Akers Biosciences Inc, a developer of health screening and testing products, said Friday that it has netted USD48,750 from wa...

16 Feb 2017 08:44

Akers Biosciences gains US patent for disposable cartridge

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, has been granted a US patent for its wellness disposable m...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.